Skip to main content

Scientific Programme

The scientific programme of the ESMINT Congress 2026 will offer a wide range of topics, teaching formats and training opportunities in the field of neurointerventions. There will be three full-days with state-of-the-art presentations, live moderation and discussions.

Explore the Programme

Programme Overview

Browse the congress schedule, sessions, timings, and programme structure directly on this page.

Interactive Online Programme

Explore the full programme including speakers, session details, and the latest updates.

Programme Overview

Wednesday, 2 Sep 2026

Main ESMINT Programme

Room: Main Lecture Hall

Time Session
08:00–08:10 Welcome and Introduction
08:10–09:00 The best & worst studies

The best studies of the last decade and what you didn´t know about them
The worst studies of the last decade and what you didn´t know about them

The conference will kick off with a high-energy session in which Jens Fiehler and Tommy Andersson review the pivotal studies of recent years that have shaped our field, examining both the breakthroughs and the challenges that have driven meaningful change.

09:00-09:30 Scientific Abstract Session I
09:30-09:45 Honorary Membership
09:45-10:00 Industry Symposium
10:00–10:30 Coffee Break & Meet the Oracle
10:30–12:00 Joint Session with EANS: The Bypass Is Dead. Long Live the Bypass?

1. Chronic vessel occlusions
Chronic vessel occlusions should primarily be treated with bypass surgery.
Chronic vessel occlusions: Why Endovascular Recanalization Should Be First-Line
2. Fusiform posterior circulation aneurysms
Natural history and time point of treatment
Posterior circulation aneurysms: No Bypass, No Solution
Fusiform posterior circulation aneurysms: endovascular only
3. Emergency bypass in acute stroke

The session throws down the gauntlet: Is bypass surgery obsolete—or on the brink of a comeback? This is where microsurgery and endovascular therapy collide—and where the future of cerebrovascular care will be fiercely reimagined.

12:00-12:30 Scientific Abstracts Session II
12:30–13:00 Industry Symposium
13:00–14:00 Lunch Break
14:00–14:30 Industry Symposium
14:30–16:00 Joint Meeting with SNIS I

1. Amy Walters Patient Lecture

Carotid stenting from zero to hero
2. CREST-2: Reasons behind CAS success
3. Beyond stenosis: Selection criteria including plaque imaging, classification
4. Impact of Embolic Protection in CAS
5. New horizons and Emerging Techniques in CAS including new devices
6. Carotid WEB
7. Tandem and dissections
8. Protection pro and contra – Panel discussion

15:45–16:00 Start-ups Session
16:00–16:30 Coffee Break & Meet the Oracle
16:30–16:45 Industry Symposium
16:45–18:00 Joint Session with SNIS II

Management of Brain AVMs and dAVF
1. The role of radiosurgery in AVM treatment
2. Brain AVM: how to use EVT, surgery and Radiosurgery for best patient outcomes
3. New embolic materials, imaging results and clinicals outcomes
4. Special population: Management of Paediatric Head, Neck, Face, and Orbital Vascular Malformation
5. Reflection and debate: SNIS and ESMINT case discussion

18:00–19:00 ESMINT General Assembly

EYMINT Meeting: Young Interventionalists@ESMINT Congress 2026

Room: EYMINT / ETMINT sessions

NEW in 2026:

Banana LogoThe EYMINT Session 2026 will feature “EYMINT goes BANANA”, a special interactive edition of the renowned BANANA course integrated into the EYMINT programme.

Across both session parts, young neurointerventionalists will present real-world cases that will be explored together with expert faculty through anatomy-focused discussion and practical decision-making.

The format combines education, case-based learning, and active audience participation in a highly dynamic setting.

Time Session
08:30–10:00 EYMINT Session – Part 1
08:30–08:50 Getting Funding: Practical Steps to a Successful Grant Application
08:50–10:00 EYMINT goes BANANA – Part 1:
Applied Imaging Anatomy
10:00–10:30 Coffee Break “Get Together EYMINT”
10:30–13:00 EYMINT Session – Part 2
10:30–12:00 EYMINT goes BANANA – Part 2:
Dural Arteriovenous Fistulas
12:00–13:00 EYMINT goes BANANA:
Bring Your Own DAVF Case

ETMINT Symposium for Angiosuite Personnel – Technicians, Nurses & Radiographers in cooperation with ESMINT

Room: EYMINT / ETMINT sessions

Time Session
14:00–16:00 ETMINT SESSION – Part 1
14:00–14:10 Introduction
14:10–14:50 Aneurysm Session
14:50–15:20 Tumor Session
15:20–16:00 When things go wrong – Complications Session
16:00–16:30 Coffee Break
16:30–18:00 ETMINT SESSION – Part 2
16:30–17:45 What`s on the horizon – R&D
17:45–18:00 Discussion & Closure

Thursday, 3 Sep 2026

Main ESMINT Programme

Room: Main Lecture Hall

Time Session
08:00–08:10 Highlights from Day 1
08:10–08:40 Scientific Abstract Session III
08:40-09:25 Precision meets pressure – inside the life of an INR

1. Invisible risk: radiation in INR and protection strategies
2. The unseen wound of INR – the weight of complications
3. Patient-ready or procedure-centered – the organization of an INR department
4. Call-schedule versus life-schedule – the new INR paradigm

This session will delve into the lesser known world of INR, exploring the hidden realities, risks, and organizational challenges we all face. We will discuss radiation exposure and new protection strategies, the psychological burden of complications, generational challenges in INR, as well as the new paradigm of patient-centered INR departments. Join us for an open and honest discussion on how these pressures shape our professional lives—and how we can build systems that better support both practitioners and patients.

09:25-09:45 Awards Session

1. Best Oral, Young Oral & ePoster Submission
2. Best European Publication in JNIS

09:45-10:00 Industry Symposium
10:00–10:30 Coffee Break & Meet the Oracle
10:30–12:30 Joint Session with ESO: Stroke Treatment – A blast from the past

1. IV Thrombolysis — History, Pharmacology, and Clinical Essentials
2. Intra-Arterial Therapy Through the Neurologist’s Lens: Indications, Evidence, and Expectations
3. Intra-Arterial Adjuncts from the Angio Suite: A Neurointerventional Perspective
4. Neuroprotection in the Thrombectomy Era: Old Concepts, New Possibilities
5. From Evidence to Action: Integrating Thrombolysis and Neuroprotection into Daily Practice

12:30–13:00 Industry Symposium
13:00–14:00 Lunch Break
14:00–14:30 Industry Symposium
14:30–14:45 Research Grants
14:45–15:05 Inspirational Talk: The Future of Neurointervention

Drawing on decades of pioneering experience, Alejandro Berenstein offers a personal and forward-looking view on where neurointervention is headed and how today’s decisions will shape its future.

15:05–16:00 Exploring new paths: Endovascular Frontiers in Neurooncology

1. Intra-Arterial Chemotherapy for Retinoblastoma: The Current State of the Art
2. Meningioma Embolization Revisited: Pre-Operative Tool or Stand-Alone Therapy?
3. Can we already Treat Malignant Brain Tumors Endovascularly?
4. How to access the brain in the future?

This session will focus on advancing neurointerventional approaches in neurooncology, including meningioma embolization, intra-arterial chemotherapy for retinoblastoma, and treatment strategies for malignant brain tumors. Emphasis will be placed on novel arterial and transvenous access routes, technical innovation, patient selection, and multidisciplinary collaboration to further improve safety, precision, and oncologic outcomes.

16:00–16:30 Coffee Break & Meet the Oracle
16:30–16:40 ESMINT Diploma Ceremony
16:40–17:40 New Technology Symposium
17:40–18:25 Ongoing & Final Trials Session

A session devoted to clinical studies, trials and registries that are related to Neurointervention, in combination with Neurology and Neurosurgery, conducted in European centers. An open call for submissions will be held. Those studies not presented in this plenary session will be displayed on a dedicated monitor in the e-poster area.

ETMINT Symposium for Angiosuite Personnel – Technicians, Nurses & Radiographers in cooperation with ESMINT

Room: EYMINT / ETMINT sessions

Time Session
09:00–10:00 ETMINT SESSION – Part 2.1
09:00–09:30 dAVF Session
09:30–10:00 Pediatric Session
10:00–10:30 Coffee Break
10:30–12:30 ETMINT SESSION – Part 2.2
10:30–12:00 Stroke Session
10:30–10:45 Public Enemy No.2 – The Clot
10:45–12:00 Stroke Workflow in different countries
12:00–12:15 Round Table/Discussion
12:15–12:20 Closure

Friday, 4 Sep 2026

Main ESMINT Programme

Room: Main Lecture Hall

Time Session
08:30–08:40 Highlights from Day 1
08:40–09:10 We are the ESMINT

1. How has education and training in INR changed over the decades and what we could expect in the future?
2. Reports from ESMINT educational programme alumni (ECMINT, EXMINT, Skills Training, Fellowship / Observership, e-Fellowship, NeuroXChange)
3. EastMINT: Remote Expertise, Real-Time Impact

In the first part, an experienced neurointerventionist will present the evolution of neurointerventional training over the years, from its origins to the present day. The focus will be in particular on the qualitative changes that have occurred over time, as well as on the regulatory and technological development—together with the quantitative growth—of our procedures.

In the second part, we will hear testimonials from participants in the various Education programs managed by ESMINT. The aim is to inform everyone about the types of programs promoted by ESMINT, to highlight their advantages, and possibly also to identify areas for improvement to be implemented in future editions.

09:10-09:30 Building Sustainable Stroke Systems: Europe and Beyond

1. Sustaining 24/7 Stroke Care Across Europe
2. Malaysias Stroke System: Constraints and Creativity

09:30-10:00 Scientific Abstract Session IV
10:00–10:30 Coffee Break & Meet the Oracle
10:30-11:00 Industry Symposium
11:00–11:45 The MMA: My best buddy

1. What clinical trials demonstrate, and what their results do NOT show
2. Complications of Middle Meningeal Artery (MMA) Embolization
3. Embolization Materials: Advantages and Efficacy
4. “Single-Stop” and Future Strategies for Chronic Subdural Hematoma (cSDH) Combined MMA embolization and hematoma drainage in one procedure, including:
• The Embolization SEPS concept
• The Embodrain system

This session is a “must-see” in the program and delivers a timely, evidence-based update on MMA embolization, critically reviewing clinical trial data, real-world complications, and anatomical risk management. By comparing embolic materials and highlighting emerging single-stop strategies for cSDH, it reflects current practice evolution and future directions in minimally invasive neurointervention.

11:45–12:30 The Venous Side of the Brain

1. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Current Evidence and Best Practice
2. Venous Causes of Pulsatile Tinnitus: from Diagnosis to Interventional Treatment
3. Transvenous Shunting: When the Vein Is the Target
4. Maxillofacial vascular malformations: specific considerations regarding therapy

The session shines a spotlight on the cerebral venous system as a rapidly evolving frontier in neurointervention. This session delivers cutting-edge insights into the evidence, techniques, and real-world challenges of venous treatments for idiopathic intracranial hypertension and pulsatile tinnitus, while also exploring the venous system as an access route and alternative to conventional surgical shunt placement. The session culminates with an expert, practice-oriented overview of contemporary strategies for treating maxillofacial vascular malformations.

12:30–12:55 Scientific Abstract Session V
12:55–13:00 Passing the Torch: Meet the 2027 Congress President!
13:00–14:00 Lunch Break
14:00–14:30 Late Breaking Abstracts
14:30–15:30 I Can See Clearly Now – The Blur is Gone

1. Flat-Panel Angiography in Focus: Unmasking the Hidden BAPAs
2. Perimesencephalic SAH: Still Benign or Just Misunderstood?
3. Risk of overdiagnosis: do we need to treat everything we see
4. Secondary MeVOs: What Flat-Panel Perfusion Reveals Beyond DSA
5. Flat-Panel CTA in Flow Diversion

This session examines how 3D flat-panel acquisition redefines neurovascular diagnostics and clinical workflows for INRs. Experts will evaluate high-resolution imaging’s role in unmasking occult pathologies, refining the classification of subarachnoid hemorrhages, and optimizing flow diversion. Discussions will prioritize leveraging advanced 3D micro-DSA and perfusion imaging data to enhance treatment precision while mitigating risks of overdiagnosis.

15:30–16:30 The case that changed me
16:30–16:40 Final Remarks/Closing